New Zealand markets close in 2 hours 1 minute

Bausch Health Companies Inc. (BHC)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
8.75-0.01 (-0.11%)
At close: 04:00PM EDT
9.48 +0.73 (+8.34%)
After hours: 07:57PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 3.23B
Enterprise value 24.67B
Trailing P/E N/A
Forward P/E 2.39
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.37
Price/book (mrq)N/A
Enterprise value/revenue 2.82
Enterprise value/EBITDA 11.21

Trading information

Stock price history

Beta (5Y monthly) 0.86
52-week change 348.56%
S&P500 52-week change 323.57%
52-week high 311.46
52-week low 35.57
50-day moving average 39.28
200-day moving average 38.31

Share statistics

Avg vol (3-month) 32.88M
Avg vol (10-day) 32.53M
Shares outstanding 5366.67M
Implied shares outstanding 6369.03M
Float 8305.92M
% held by insiders 10.91%
% held by institutions 179.41%
Shares short (15 Apr 2024) 420.71M
Short ratio (15 Apr 2024) 45.48
Short % of float (15 Apr 2024) 47.49%
Short % of shares outstanding (15 Apr 2024) 45.65%
Shares short (prior month 15 Mar 2024) 423.78M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 46.52
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 410 Nov 2010
Last split factor 22:1
Last split date 316 Oct 2000

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -6.76%
Operating margin (ttm)21.06%

Management effectiveness

Return on assets (ttm)3.82%
Return on equity (ttm)-686.52%

Income statement

Revenue (ttm)8.76B
Revenue per share (ttm)24.00
Quarterly revenue growth (yoy)9.80%
Gross profit (ttm)N/A
EBITDA 2.88B
Net income avi to common (ttm)-592M
Diluted EPS (ttm)-1.62
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)947M
Total cash per share (mrq)2.59
Total debt (mrq)22.6B
Total debt/equity (mrq)N/A
Current ratio (mrq)1.30
Book value per share (mrq)-2.80

Cash flow statement

Operating cash flow (ttm)1.03B
Levered free cash flow (ttm)738.12M